Chlorambucil arrests cell cycle at the G2 (premitotic) stage. It crosses cross-linking of the cellular DNA strands. DNA breaks down and cell dies.
Chronic Lymphocytic Leukaemia (drug of choice), Primary (Waldenstrom's) macroglobulinaemia, advanced ovarian adeno carcinoma, breast cancer, certain forms of non-Hodgkin's Lymphoma, Hodgkin's disease.
After oral administration it shows reliable and adequate absorption. It is almost completely metabolised.
Hypersensitivity.
Nausea, vomiting, epigastric discomfort, pulmonary fibrosis, dermatitis, seizures, hepatotoxicity, amenorrhoea, azoospermia, bone marrow depression. Peripheral neuropathy.
Carcinogenic potential, altered fertility, haematological monitoring, extravasation, hyperuricaemia, porphyria.
0.1
- 0.2mg / kg body weight daily for 4-8 weeks. For chronic lymphocytic
leukaemia - 0.4mg / kg bi weekly or monthly. Increased by 0.1mg / kg
till lymphocytosis is controlled. Maintenance
dose : 0.1mg/kg per day or may be low dose of 0.03 mg/kg. Children : Not recommended.
15 - 30 mins.
Terminal elimination half-life 2 - 2.5 hours.
2mg
tablet,
Shree Ganesh
Pharmaceuticals
|
|||||||||||||||||||
|
Disclaimer
: This guide is provided for information purposes only, and for use
of a registered medical practitioner or a hospital or a laboratory only.
The authors, webmaster, or respective references / links are no way
responsible for the content of the information. Although a concerted
effort has been made to ensure the validity of the information contained
in this document, we give no
assurance for the accuracy of the information in this documents. |